Harrow Health, Inc.HROWNASDAQ
Loading
Year-over-year net income growth rate
3Y CAGR
+67.8%/yr
Quarterly compound
Percentile
P95
Near historical high
vs 3Y Ago
4.7x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 549.61% |
| Q3 2025 | -79.58% |
| Q2 2025 | 128.09% |
| Q1 2025 | -362.36% |
| Q4 2024 | 260.59% |
| Q3 2024 | 34.81% |
| Q2 2024 | 52.28% |
| Q1 2024 | -48.28% |
| Q4 2023 | -108.34% |
| Q3 2023 | -3.83% |
| Q2 2023 | 36.34% |
| Q1 2023 | -729.67% |
| Q4 2022 | 116.32% |
| Q3 2022 | -3.61% |
| Q2 2022 | -155.91% |
| Q1 2022 | 67.13% |
| Q4 2021 | 10.93% |
| Q3 2021 | -236.08% |
| Q2 2021 | -1241.94% |
| Q1 2021 | -81.11% |
| Q4 2020 | -86.70% |
| Q3 2020 | 3744.73% |
| Q2 2020 | 98.16% |
| Q1 2020 | -585.77% |
| Q4 2019 | 123.17% |
| Q3 2019 | -382.30% |
| Q2 2019 | -120.94% |
| Q1 2019 | -37.35% |
| Q4 2018 | 821.16% |
| Q3 2018 | -199.68% |
| Q2 2018 | 171.79% |
| Q1 2018 | -26.78% |
| Q4 2017 | 51.32% |
| Q3 2017 | -483.56% |
| Q2 2017 | 129.64% |
| Q1 2017 | 17.96% |
| Q4 2016 | -58.49% |
| Q3 2016 | 17.01% |
| Q2 2016 | -3.18% |
| Q1 2016 | 12.26% |